Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Clinical trial NCT02165202 · COMPLETED

Trial details

NCT number: NCT02165202
Sponsor: PATH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)

Start date: 2014-10-01
Primary completion: 2015-04-13
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.